Jamil Kendall, MD
Adult Reconstructive Orthopaedic Surgery · Palos Heights, ILNPI 1508360819
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (33.9%), grants and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Smith+Nephew at 48.3% of the total. Reporting peaked in 2024 at $8,584 and has fallen 71.3% since, to $2,465 in 2025.
Across 110 payments — averaging $157.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Stryker$4K
- Medical Device Business Services, Inc.$2K
- Linkbio Corp$861
- Zimmer Biomet$846
- Orthalign Inc$469
- plus $1K from 8 others
What the payments were for
- Consulting fees$6754%
- Grants$4,16724%
- Travel & lodging$2,41414%
- Food & beverage$5,85734%
- Education$4,16724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $8,354 |
| Stryker | 46 | $3,853 |
| Medical Device Business Services, Inc. | 8 | $1,528 |
| Linkbio Corp | 2 | $861 |
| Zimmer Biomet | 21 | $846 |
| Orthalign Inc | 5 | $469 |
| Medtronic | 10 | $460 |
| Johnson & Johnson | 3 | $329 |
| Omnilife Science, Inc | 6 | $162 |
| Globus Medical | 1 | $159 |
| Organogenesis Inc. | 2 | $115 |
| Davol Inc. | 1 | $100 |
| UOC USA Inc | 1 | $24 |
| Moximed, Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,598
- Velys$1,397
- PANGEA$573
- INSIGNIA$472
- GAMMA$376
- ORTHALIGN PLUS$375
- TRIATHLON$291
- EVO Retrograde$159
- G7$159
- Avenir$154
- T2 ALPHA$145
- ACTIS$127
- OSS Orthopedic Salvage System$120
- AQUAMANTYS$111
How this compares
$17,279 in reported general payments places this provider in the 55th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.
See all adult reconstructive orthopaedic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 25 | $86 |
| Tramadol Hcl | 12 | $23 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Palos Heights
- Wayne PaproskyWinfield$10.9M
- Scott SporerWinfield$5.3M
- Denis NamChicago$3.2M
- Craig della ValleChicago$2.4M
- Hany BedairChicago$1.1M
- Linda SuleimanChicago$898K
- Tad GerlingerChicago$642K
- Henry FinnChicago$523K
- Vasili KarasChicago$264K
- Brett LevineChicago$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.